Investors expect Medpace Holdings to outperform the market, hence its high P/E ratio. Strong future growth anticipation makes investors pay more for the stock, supporting the share price.
Medpace Holdings' robust conversion of profit to free cash flow is promising. Its underlying earnings potential may even surpass the statutory profit. Its earnings per share have seen a remarkable growth over the past three years.
Medpace Holdings' market sentiment remains steady, mirroring EPS growth. The stock's recent performance shows improvement, with a 90% shareholder return over the last year, surpassing the five-year TSR of 41% per year. The strong share price momentum suggests a closer look at the stock may be worthwhile.
Medpace's high P/E is backed by its forecast growth being higher than the wider market. Investors are quite confident in the company's future earnings and seem willing to pay more for the stock, suggesting a bullish outlook.
Insider selling at current price (US$274) is less worrying, but there were no purchases over the past year to boost confidence. A high level of insider ownership often implies interests of all shareholders are considered, though recent history of share sales triggers some hesitation.
Medpace's market sentiment appears constant over years, mirroring its EPS growth. The company's five-year total shareholder return of 38% per year impresses.
Upgrades •$マルケタ(MQ.US)$: Morgan Stanley Upgrades to Overweight from Equalweight - PT $15 •$ノースウェスト・ナチュラル・ホールディング(NWN.US)$: BofA Securities Upgrades to Neutral from Underperform - PT $53 (from $51) •$オーチス・ワールドワイド(OTIS.US)$: Barclays Upgrades to Overweight from Equalweight - PT $82 (from $80) •$スノーフレーク(SNOW.US)$: Rosenblatt Upgrades to Buy from Neutral - PT $255 (from $325) Downgrades •$イートン(ETN.US)$: Barclays Downgrades to Underweight from Eq...
メドペース・ホールディングスに関するコメント
コラムUS Top Gap Ups and Downs on 4/25: SPOT, MEDP, FRC, DB and More
Gap Ups
1. $メドペース・ホールディングス(MEDP.US)$ - up 8.3%
2. $ハベル(HUBB.US)$ - up 7.3%
3. $ノバルティス(NVS.US)$ - up 2.6%
4. $スポティファイ・テクノロジー(SPOT.US)$ - up 1.9%
5. $ABB(ABB.US)$ - up 1.8%
6. $センティーン(CNC.US)$ - up 1.5%
7. $キンバリークラーク(KMB.US)$ - up 0.9%
8. $野村ホールディングス(NMR.US)$ ...
コラムUS Top Gap Ups and Downs on 10/25: LOGI, UBS, RBLX, CVS and More
Gap Ups
1. $メドペース・ホールディングス(MEDP.US)$ - up 25.01%
2. $ロジテック・インターナショナル(LOGI.US)$ - up 8.07%
3. $UBSグループ(UBS.US)$ - up 5.36%
4. $エスエイピー(SAP.US)$ - up 5.30%
5. $チャールズリバー・ラボラトリーズ・インターナショナル(CRL.US)$ - up 4.30%
6. $IQVIAホールディングス(IQV.US)$ - up 3.77%
7. $ユーホール・ホールディング・カンパニー(UHAL.US)$ - up 2.80%
8. $ロブロックス(RBLX.US)$...
10/25 Watchlist
Follow for nightly watchlist ⭐️
$Applied Genetic(AGTC.US)$$ALFI Inc(ALF.US)$$アリババ・グループ・ホールディング(BABA.US)$$ビヨンド・カンナソフト・エンタープライゼス(BCAN.US)$$ディスカバー・ファイナンシャル・サービシズ(DFS.US)$$ロジテック・インターナショナル(LOGI.US)$$メドペース・ホールディングス(MEDP.US)$$スリーエム(MMM.US)$$ミューレン・オートモーティブ(MULN.US)$$Tricida(TCDA.US)$$シャオペン(XPEV.US)$$Qualtrics International(XM.US)$
コラムTop upgrades and downgrades on 5/24
• $マルケタ(MQ.US)$ : Morgan Stanley Upgrades to Overweight from Equalweight - PT $15
• $ノースウェスト・ナチュラル・ホールディング(NWN.US)$ : BofA Securities Upgrades to Neutral from Underperform - PT $53 (from $51)
• $オーチス・ワールドワイド(OTIS.US)$ : Barclays Upgrades to Overweight from Equalweight - PT $82 (from $80)
• $スノーフレーク(SNOW.US)$ : Rosenblatt Upgrades to Buy from Neutral - PT $255 (from $325)
Downgrades
• $イートン(ETN.US)$ : Barclays Downgrades to Underweight from Eq...
まだコメントはありません